Published in Transplantation on September 27, 2007
IL-6 and TNF-alpha synergistically inhibit allograft acceptance. J Am Soc Nephrol (2009) 1.10
TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection. Immunotherapy (2010) 0.92
Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells. J Immunol (2011) 0.90
IL-6 promotes cardiac graft rejection mediated by CD4+ cells. J Immunol (2011) 0.89
The intimate relationship between human cytomegalovirus and the dendritic cell lineage. Front Microbiol (2014) 0.85
The innate immune system in transplantation. Semin Immunol (2011) 0.84
The mechanisms of up-regulation of dendritic cell activity by oxidative stress. J Leukoc Biol (2014) 0.79
Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8+ memory T cells. Am J Transplant (2009) 0.79
Impact of Immune-Modulatory Drugs on Regulatory T Cell. Transplantation (2016) 0.77
Haptoglobin enhances cardiac transplant rejection. Circ Res (2015) 0.77
Alteration of innate immunity by donor IL-6 deficiency in a presensitized heart transplant model. PLoS One (2013) 0.77
Novel Application of Localized Nanodelivery of Anti-Interleukin-6 Protects Organ Transplant From Ischemia-Reperfusion Injuries. Am J Transplant (2017) 0.76
Combining Theoretical and Experimental Techniques to Study Murine Heart Transplant Rejection. Front Immunol (2016) 0.75
A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation. Transplantation (2016) 0.75
Safety and Efficacy of Transplantation with Allogeneic Skin Tumors to Treat Chemically-Induced Skin Tumors in Mice. Med Sci Monit (2016) 0.75
Creating transplant tolerance by taming adverse intragraft innate immunity. F1000 Biol Rep (2010) 0.75
IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts. J Immunol (2016) 0.75
Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest (2006) 3.11
Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med (2002) 2.32
In vivo optical imaging of pleural space drainage to lymph nodes of prognostic significance. Ann Surg Oncol (2004) 2.13
Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg (2005) 1.98
Modified T-tube repair of delayed esophageal perforation results in a low mortality rate similar to that seen with acute perforations. Ann Thorac Surg (2007) 1.78
Hubs in biological interaction networks exhibit low changes in expression in experimental asthma. Mol Syst Biol (2007) 1.69
Sentinel lymph node mapping of the pleural space. Chest (2005) 1.67
Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg (2007) 1.66
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2006) 1.64
The lung corps' approach to reducing health disparities in respiratory disease. Ann Am Thorac Soc (2014) 1.48
Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system. J Am Chem Soc (2009) 1.46
The public health benefits of air pollution control. J Allergy Clin Immunol (2012) 1.41
Lymphatic drainage of the peritoneal space: a pattern dependent on bowel lymphatics. Ann Surg Oncol (2007) 1.41
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy. Chest (2002) 1.40
Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release (2011) 1.39
Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg (2011) 1.34
Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol (2004) 1.31
The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J Immunol (2004) 1.20
Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol (2002) 1.19
Intraoperative localization of insulinoma and normal pancreas using invisible near-infrared fluorescent light. Ann Surg Oncol (2009) 1.16
Superhydrophobic materials for tunable drug release: using displacement of air to control delivery rates. J Am Chem Soc (2012) 1.12
Lung resection in patients with preoperative FEV1 < 35% predicted. Chest (2005) 1.11
Re-sampling strategy to improve the estimation of number of null hypotheses in FDR control under strong correlation structures. BMC Bioinformatics (2007) 1.08
Neonatal immune responses to TLR2 stimulation: influence of maternal atopy on Foxp3 and IL-10 expression. Respir Res (2006) 1.05
Absence of clinical GVHD and the in vivo induction of regulatory T cells after transplantation of facilitating cells. Blood (2004) 1.05
TLR2 and TLR4 stimulation differentially induce cytokine secretion in human neonatal, adult, and murine mononuclear cells. J Interferon Cytokine Res (2004) 1.04
Induction of FoxP3+CD4+25+ regulatory T cells following hemopoietic stem cell transplantation: role of bone marrow-derived facilitating cells. J Immunol (2007) 1.02
Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol (2013) 1.00
Prevention of in vivo lung tumor growth by prolonged local delivery of hydroxycamptothecin using poly(ester-carbonate)-collagen composites. J Control Release (2010) 0.99
Rituximab in the treatment of refractory pulmonary sarcoidosis. Eur Respir J (2014) 0.98
Infant home endotoxin is associated with reduced allergen-stimulated lymphocyte proliferation and IL-13 production in childhood. J Allergy Clin Immunol (2005) 0.97
Envisioning simulation in the future of thoracic surgical education. J Thorac Cardiovasc Surg (2008) 0.96
3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells. J Control Release (2012) 0.96
Microscopy and tunable resistive pulse sensing characterization of the swelling of pH-responsive, polymeric expansile nanoparticles. Nanoscale (2013) 0.94
Cutting edge: Deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses. J Immunol (2006) 0.94
T cell pathways involving CTLA4 contribute to a model of acute lung injury. J Immunol (2010) 0.94
Allergen-induced cytokine production, atopic disease, IgE, and wheeze in children. J Allergy Clin Immunol (2003) 0.94
Alterations in lung collectins in an adaptive allergic immune response. Am J Physiol Lung Cell Mol Physiol (2002) 0.93
Innate immune mechanism in allergic asthma. Curr Allergy Asthma Rep (2008) 0.92
Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy. Ann Surg Oncol (2011) 0.91
Cord blood cytokines and acute lower respiratory illnesses in the first year of life. Pediatrics (2006) 0.90
Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging. J Thorac Cardiovasc Surg (2013) 0.90
Induction of FoxP3+CD4+CD25+ regulatory T cells by a bone marrow population distinct from plasmacytoid-DC. Cell Immunol (2008) 0.89
Analysis of robust innate immune response after transplantation in the absence of adaptive immunity. Transplantation (2002) 0.89
Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles. Biomaterials (2012) 0.89
Genomics and proteomics of lung disease: conference summary. Am J Physiol Lung Cell Mol Physiol (2007) 0.88
Sex and gender differences in non-small cell lung cancer. Semin Thorac Cardiovasc Surg (2011) 0.88
Maternity policy and practice during surgery residency: how we do it. Surgery (2002) 0.87
Paclitaxel-loaded expansile nanoparticles delay local recurrence in a heterotopic murine non-small cell lung cancer model. Ann Thorac Surg (2011) 0.87
Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published literature. Brachytherapy (2008) 0.87
Lung transplantation: infection, inflammation, and the microbiome. Semin Immunopathol (2011) 0.86
Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J Immunol (2002) 0.86
Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films. Ann Surg Oncol (2009) 0.86
Surfactant protein D-mediated decrease of allergen-induced inflammation is dependent upon CTLA4. J Immunol (2010) 0.86
The WTS report on the current status of women in cardiothoracic surgery. Ann Thorac Surg (2012) 0.85
Prenatal, perinatal, and heritable influences on cord blood immune responses. Ann Allergy Asthma Immunol (2006) 0.85
Functionalized hydrophobic poly(glycerol-co-ε-caprolactone) depots for controlled drug release. Biomacromolecules (2012) 0.84
Clarithromycin use preceding fulminant hepatic failure. Am J Gastroenterol (2002) 0.84
In vitro activity of Paclitaxel-loaded polymeric expansile nanoparticles in breast cancer cells. Biomacromolecules (2013) 0.84
CD45RB ligation inhibits allergic pulmonary inflammation by inducing CTLA4 transcription. J Immunol (2007) 0.84
An official American Thoracic Society/European Respiratory Society policy statement: disparities in respiratory health. Am J Respir Crit Care Med (2013) 0.84
The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection. Prostaglandins Leukot Essent Fatty Acids (2010) 0.84
Developing intrathoracic sentinel lymph node mapping with near-infrared fluorescent imaging in non-small cell lung cancer. J Thorac Cardiovasc Surg (2012) 0.84
CD45 ligation expands Tregs by promoting interactions with DCs. J Clin Invest (2014) 0.84
Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal model. J Am Coll Surg (2012) 0.84
Cytoreductive surgery and intraoperative administration of paclitaxel-loaded expansile nanoparticles delay tumor recurrence in ovarian carcinoma. Ann Surg Oncol (2012) 0.84
Molecular profiling of the role of the NF-kappaB family of transcription factors during alloimmunity. J Leukoc Biol (2002) 0.83
Hydrogels as intracellular depots for drug delivery. Mol Pharm (2011) 0.83
Nuclear factor kappa B activation in human cord blood mononuclear cells. Pediatr Res (2004) 0.83
Paclitaxel-loaded expansile nanoparticles in a multimodal treatment model of malignant mesothelioma. Ann Thorac Surg (2011) 0.83
The graft response to transplantation: a gene expression profile analysis. Physiol Genomics (2003) 0.82
(R)-albuterol decreases immune responses: role of activated T cells. Respir Res (2008) 0.82
Preclinical study of near-infrared-guided sentinel lymph node mapping of the porcine lung. Ann Thorac Surg (2012) 0.81
Associations of cord blood fatty acids with lymphocyte proliferation, IL-13, and IFN-gamma. J Allergy Clin Immunol (2006) 0.81
Ease of synthesis, controllable sizes, and in vivo large-animal-lymph migration of polymeric nanoparticles. ChemMedChem (2010) 0.81
MDCT evaluation of central airway and vascular complications of lung transplantation. AJR Am J Roentgenol (2008) 0.81
Costimulation and allergic responses: immune and bioinformatic analyses. Pharmacol Ther (2007) 0.81
Emerging pathways in asthma: innate and adaptive interactions. Biochim Biophys Acta (2011) 0.80
MHC class II-associated invariant chain isoforms regulate pulmonary immune responses. J Immunol (2003) 0.80
Molecular profiles of allograft rejection following inhibition of CD40 ligand costimulation differentiated by cluster analysis. J Leukoc Biol (2002) 0.80
Toll receptors modulate allergic responses: interaction with dendritic cells, T cells and mast cells. Curr Opin Allergy Clin Immunol (2003) 0.80